Acer Therapeutics Inc (NASDAQ:ACER)

2.03
BATS BZX Real-Time Price
As of 11:13am ET
 -0.03 / -1.46%
Today’s Change
1.08
Today|||52-Week Range
28.25
-49.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$17.7M

Company Description

Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA.

Contact Information

Acer Therapeutics, Inc.
One Gateway Center
Newton Massachusetts 02458
P:(844) 902-6100
Investor Relations:
844

Employees

Shareholders

Mutual fund holders6.76%
Individual stakeholders45.35%
Other institutional17.29%

Top Executives

There are no executives to display.